Visual Function in Children with GNAO1-Related Encephalopathy.


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
22 02 2023
Historique:
received: 07 12 2022
revised: 09 02 2023
accepted: 20 02 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

GNAO1-related encephalopathies include a broad spectrum of developmental disorders caused by de novo heterozygous mutations in the GNAO1 gene, encoding the G (o) subunit α of G-proteins. These conditions are characterized by epilepsy, movement disorders and developmental impairment, in combination or as isolated features. This study aimed at describing the profile of neurovisual competences in children with GNAO1 deficiency to better characterize the phenotype of the disease spectrum. Four male and three female patients with confirmed genetic diagnosis underwent neurological examination, visual function assessment, and neurovisual and ophthalmological evaluation. Present clinical history of epilepsy and movement disorders, and neuroimaging findings were also evaluated. The assessment revealed two trends in visual development. Some aspects of visual function, such as discrimination and perception of distance, depth and volume, appeared to be impaired at all ages, with no sign of improvement. Other aspects, reliant on temporal lobe competences (ventral stream) and more related to object-face exploration, recognition and environmental control, appeared to be preserved and improved with age. Visual function is often impaired, with patterns of visual impairment affecting the ventral stream less.

Sections du résumé

BACKGROUND
GNAO1-related encephalopathies include a broad spectrum of developmental disorders caused by de novo heterozygous mutations in the GNAO1 gene, encoding the G (o) subunit α of G-proteins. These conditions are characterized by epilepsy, movement disorders and developmental impairment, in combination or as isolated features.
OBJECTIVE
This study aimed at describing the profile of neurovisual competences in children with GNAO1 deficiency to better characterize the phenotype of the disease spectrum.
METHODS
Four male and three female patients with confirmed genetic diagnosis underwent neurological examination, visual function assessment, and neurovisual and ophthalmological evaluation. Present clinical history of epilepsy and movement disorders, and neuroimaging findings were also evaluated.
RESULTS
The assessment revealed two trends in visual development. Some aspects of visual function, such as discrimination and perception of distance, depth and volume, appeared to be impaired at all ages, with no sign of improvement. Other aspects, reliant on temporal lobe competences (ventral stream) and more related to object-face exploration, recognition and environmental control, appeared to be preserved and improved with age.
SIGNIFICANCE
Visual function is often impaired, with patterns of visual impairment affecting the ventral stream less.

Identifiants

pubmed: 36980817
pii: genes14030544
doi: 10.3390/genes14030544
pmc: PMC10047968
pii:
doi:

Substances chimiques

GNAO1 protein, human 0
GTP-Binding Protein alpha Subunits, Gi-Go EC 3.6.5.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Behav Brain Res. 1992 Jul 31;49(1):115-22
pubmed: 1388794
Prog Brain Res. 2011;189:261-83
pubmed: 21489394
Epilepsy Res. 2011 Jan;93(1):73-9
pubmed: 21109403
Am J Hum Genet. 2013 Sep 5;93(3):496-505
pubmed: 23993195
J Child Neurol. 2016 Dec;31(14):1598-1601
pubmed: 27625011
Neurology. 2017 Aug 22;89(8):762-770
pubmed: 28747448
Eur J Hum Genet. 2016 Jan;24(1):129-34
pubmed: 25966631
Front Hum Neurosci. 2021 Nov 24;15:703217
pubmed: 34899210
Parkinsonism Relat Disord. 2019 Apr;61:19-25
pubmed: 30642806
J Neurol Sci. 2018 Aug 15;391:31-39
pubmed: 30103967
Epilepsia. 2017 Apr;58(4):531-542
pubmed: 28276064
Epilepsia. 2004 Jul;45(7):781-6
pubmed: 15230702
Arch Ophthalmol. 1981 Mar;99(3):439-45
pubmed: 7213162
Genes (Basel). 2021 Jun 25;12(7):
pubmed: 34202106
Eye (Lond). 1996;10 ( Pt 2):286-90
pubmed: 8776462
Epilepsia. 2015 Oct;56(10):1515-23
pubmed: 26336950
Dev Med Child Neurol. 1988 Apr;30(2):232-44
pubmed: 3384203
Front Neurol. 2022 Jan 26;12:805745
pubmed: 35153983
Neurol Genet. 2017 Mar 21;3(2):e143
pubmed: 28357411
Mov Disord Clin Pract. 2016 Mar 11;3(6):615-617
pubmed: 30838255
Neurobiol Dis. 2018 Aug;116:131-141
pubmed: 29758257
Prog Brain Res. 2007;164:151-68
pubmed: 17920430
Child Neurol Open. 2015 May 05;2(2):2329048X15583717
pubmed: 28503590
Orphanet J Rare Dis. 2016 Apr 12;11:38
pubmed: 27072799
Ther Adv Neurol Disord. 2022 Apr 29;15:17562864221093507
pubmed: 35509770
Epilepsia. 2019 Mar;60(3):406-418
pubmed: 30682224
Dev Med Child Neurol. 1997 Apr;39(4):214-23
pubmed: 9183258
J Clin Med. 2021 Aug 12;10(16):
pubmed: 34441836
Vision Res. 1986;26(6):909-16
pubmed: 3750874
Brain Res Cogn Brain Res. 2005 Dec;25(3):788-98
pubmed: 16256320

Auteurs

Maria Luigia Gambardella (ML)

Pediatric Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Elisa Pede (E)

Pediatric Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Lorenzo Orazi (L)

National Centre of Services and Research for the Prevention of Blindness and Rehabilitation of Visually Impaired, IAPB Italia ONLUS, 00168 Rome, Italy.
Ophthalmology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Simona Leone (S)

National Centre of Services and Research for the Prevention of Blindness and Rehabilitation of Visually Impaired, IAPB Italia ONLUS, 00168 Rome, Italy.
Ophthalmology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Michela Quintiliani (M)

Pediatric Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Giulia Maria Amorelli (GM)

National Centre of Services and Research for the Prevention of Blindness and Rehabilitation of Visually Impaired, IAPB Italia ONLUS, 00168 Rome, Italy.
Ophthalmology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Maria Petrianni (M)

National Centre of Services and Research for the Prevention of Blindness and Rehabilitation of Visually Impaired, IAPB Italia ONLUS, 00168 Rome, Italy.
Ophthalmology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Marta Galanti (M)

National Centre of Services and Research for the Prevention of Blindness and Rehabilitation of Visually Impaired, IAPB Italia ONLUS, 00168 Rome, Italy.
Ophthalmology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Filippo Amore (F)

National Centre of Services and Research for the Prevention of Blindness and Rehabilitation of Visually Impaired, IAPB Italia ONLUS, 00168 Rome, Italy.
Ophthalmology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Elisa Musto (E)

Pediatric Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Marco Perulli (M)

Pediatric Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Ilaria Contaldo (I)

Pediatric Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Chiara Veredice (C)

Pediatric Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Eugenio Maria Mercuri (EM)

Pediatric Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Domenica Immacolata Battaglia (DI)

Pediatric Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Daniela Ricci (D)

Pediatric Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
National Centre of Services and Research for the Prevention of Blindness and Rehabilitation of Visually Impaired, IAPB Italia ONLUS, 00168 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH